½ÃÀ庸°í¼­
»óǰÄÚµå
1635849

½Å°æ¿Ü°ú ¼ö¼ú½Ç¿ë ÀΰøÁö´É(AI) ½ÃÀå : Á¦°øº°, ±â¼úº°, ÀûÀÀÁõº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)

Artificial Intelligence in Neurology Operating Room Market by Offering, Technology, Indication, Application, End User, and Region 2025-2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 137 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½Å°æ¿Ü°ú ¼ö¼ú½Ç¿ë ÀΰøÁö´É(AI) ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 6,360¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â¿¡´Â 12¾ï 9,700¸¸ ´Þ·¯¿¡ ´ÞÇØ 2025³âºÎÅÍ 2033³â±îÁö 39.8%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ±Þ¼ºÀåÇÏ´Â ÇコÄÉ¾î »ê¾÷, ½ÉÀå ¹× »óó ÇÕº´Áõ ¿¹ÃøÀ» À§ÇÑ ½Å°æ¿Ü°ú ¼ö¼ú½Ç¿¡¼­ÀÇ AI Ȱ¿ë Áõ°¡, AI ±â¹Ý ·Îº¿ ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎ Áß ÀϺÎÀÔ´Ï´Ù.

ÀΰøÁö´É(AI)Àº ÄÄÇ»ÅÍ ÇÁ·Î±×·¥À̳ª ±â°è¸¦ ÅëÇØ Àΰ£ÀÇ Áö´É °úÁ¤À» ½Ã¹Ä·¹À̼ÇÇÏ´Â °ÍÀ» ¸»ÇÕ´Ï´Ù. Àü¹®°¡ ½Ã½ºÅÛ, ÀÚ¿¬¾î ó¸®, À½¼º ÀνÄ, ¸Ó½ÅºñÀüÀ¸·Î ±¸¼ºµÇ¸ç, AI´Â ±â°è ÇнÀ(ML) ¾Ë°í¸®ÁòÀÇ »ý¼º ¹× ÇнÀÀ» À§ÇÑ °­È­µÈ Çϵå¿þ¾î ¹× ¼ÒÇÁÆ®¿þ¾î ±â¹Ý¿¡ ÀÇÁ¸ÇÕ´Ï´Ù. ½Ç¼ö¸¦ ÁÙÀ̰í, À§ÇèÇÑ ÀÛ¾÷À» ¼öÇàÇϸç, ´Ù¾çÇÑ ÀÛ¾÷À» ½¬Áö ¾Ê°í ÀÚµ¿È­Çϱâ À§ÇØ Ã¤Åõǰí ÀÖ½À´Ï´Ù. ´ë·®ÀÇ ¶óº§ÀÌ ºÙÀº ÇнÀ µ¥ÀÌÅ͸¦ ¼öÁýÇϰí, µ¥ÀÌÅ͸¦ ºÐ¼®ÇÏ¿© »ó°ü°ü°è¿Í ÆÐÅÏÀ» ã°í, ÀÌ·¯ÇÑ ÆÐÅÏÀ» »ç¿ëÇÏ¿© ¹Ì·¡ »óÅ¿¡ ´ëÇÑ ¿¹ÃøÀ» ¼öÇàÇÕ´Ï´Ù. ¶ÇÇÑ µ¥ÀÌÅ͸¦ ¼öÁýÇÏ°í µ¥ÀÌÅ͸¦ ½Ç¿ëÀûÀÎ Á¤º¸·Î º¯È¯ÇÏ¿© ƯÁ¤ ÀÛ¾÷À» »ý¼ºÇÏ´Â µ¥ µµ¿òÀ» ÁÝ´Ï´Ù. ÇöÀç ½Å°æ¿Ü°ú ¼ö¼ú½Ç¿¡¼­´Â ¿Ü°ú ÀÇ»çÀÇ ¼º°ú¸¦ ³ôÀÌ°í ½Å°æ¿Ü°ú ¼ö¼ú°ú °ü·ÃµÈ ¿À·ù¸¦ ÁÙÀ̱â À§ÇØ AI¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

½Å°æ¿Ü°ú ¼ö¼ú½Ç¿ë ÀΰøÁö´É(AI) ½ÃÀå µ¿Çâ:

¿¹ÈÄ ¿¹Ãø, ÀáÀçÀûÀÎ ¼ö¼ú ÈÄ ÇÕº´Áõ ½Äº°, ´õ ³ªÀº »çÈÄ °ü¸® ¹× ȸº¹À» À§ÇÑ µ¥ÀÌÅÍ ÃßÀûÀ» À§ÇÑ ½Å°æ¿Ü°ú ¼ö¼ú½Ç¿¡¼­ÀÇ AI ¼ö¿ä Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ÀÌ¿Í ´õºÒ¾î, Àü ¼¼°èÀûÀ¸·Î °æÃß Àü¹æ Ãß°£ÆÇ ÀýÁ¦¼ú(ACDF)À» ¹Þ´Â ȯÀÚÀÇ À§Çè ¿äÀÎÀ» ½Äº°Çϰí, ½ÉÀå ÇÕº´Áõ, »óó ÇÕº´Áõ, »ç¸Á·üÀ» ¿¹ÃøÇϱâ À§ÇØ ½Å°æ¿Ü°ú ¼ö¼ú½Ç¿¡¼­ AIÀÇ »ç¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ÇコÄÉ¾î »ê¾÷ÀÇ ¹ø¿µ°ú ÇÔ²² ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, µ¥ÀÌÅÍ ¼öÁý, ºÐ¼®, ó¸® ¹× º¸±ÞÀ» À§ÇØ ½Å°æ¿Ü°ú ¿¬±¸ ¼¾ÅÍ¿¡¼­ AI¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀå Àü¸ÁÀ» ¹à°Ô Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ °£Áú, Á¾¾ç À¯Çü, ½Å°æ±³Á¾, ±Þ¼º ÇãÇ÷¼º Áúȯ, ³úµ¿¸Æ·ù Áø´ÜÀ» À§ÇÑ AIÀÇ Ã¤ÅÃÀÌ Àü ¼¼°èÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ±âÁ¸ ¼ö¼úº¸´Ù AI¸¦ Ȱ¿ëÇÑ ¼ö¼úÀÌ ´õ ³´´Ù´Â ´ëÁßÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î, ÃÖ¼Òħ½À(MI), ºü¸¥ ȸº¹°ú ÀûÀº ÃâÇ÷À» °¡Á®¿À´Â AI ±â¹Ý ·Îº¿ ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ¾÷°è ÅõÀÚÀڵ鿡°Ô À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿ø°Ý ¼ö¼ú ´É·ÂÀ» °­È­Çϱâ À§ÇÑ AIÀÇ Àû¿ëÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

  • ½Å°æ¿Ü°ú ¼ö¼ú½Ç¿ë ÀΰøÁö´É(AI) ¼¼°è ½ÃÀåÀº Áö±Ý±îÁö ¾î¶»°Ô ¼ºÀåÇØ¿ÔÀ¸¸ç, ÇâÈÄ ¸î ³â µ¿¾È ¾î¶»°Ô º¯È­ÇÒ °ÍÀΰ¡?
  • ½Å°æ¿Ü°ú ¼ö¼ú½Ç¿ë ÀΰøÁö´É(AI) ¼¼°è ½ÃÀå¿¡¼­ÀÇ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ´Â ¹«¾ùÀΰ¡?
  • ÁÖ¿ä Áö¿ª ½ÃÀåÀº?
  • ½Å°æ¿Ü°ú¿ë ÀΰøÁö´É(AI) ½ÃÀå¿¡¼­ °¡Àå ¸Å·ÂÀûÀÎ ±¹°¡´Â?
  • Á¦°øº° ½ÃÀå ³»¿ªÀº?
  • ±â¼úº° ½ÃÀå ºÐ¼®Àº?
  • ÀûÀÀÁõ¿¡ µû¸¥ ½ÃÀå ºÐ¼®Àº?
  • ¿ëµµº° ½ÃÀå ³»¿ªÀº?
  • ÃÖÁ¾»ç¿ëÀÚº° ½ÃÀå ºÐ¼®Àº ¾î¶»°Ô µÇ´Â°¡?
  • ½Å°æ¿Ü°ú ¼ö¼ú½Ç¿ë ÀΰøÁö´É(AI) ¼¼°è ½ÃÀå °æÀï ±¸µµ´Â?
  • ½Å°æ¿Ü°ú ¼ö¼ú½Ç¿ë ÀΰøÁö´É(AI) ¼¼°è ½ÃÀåÀÇ ÁÖ¿ä Ç÷¹À̾î/±â¾÷Àº?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ½Å°æ¿Ü°ú ¼ö¼ú½Ç¿ë ÀΰøÁö´É(AI) ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ³»¿ª : Á¦°øº°

  • Çϵå¿þ¾î
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • SaaS
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦7Àå ½ÃÀå ³»¿ª : ±â¼úº°

  • ¸Ó½Å·¯´×(ML)°ú µö·¯´×
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ÀÚ¿¬¾î ó¸®(NLP)
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±âŸ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦8Àå ½ÃÀå ³»¿ª : ÀûÀÀÁõº°

  • ´º·ÎÅ×Å©³î·¯Áö
    • ½ÃÀå µ¿Çâ
    • ÁÖ¿ä ºÎ¹®
      • ½Å°æ¸ð´ÏÅ͸µ
      • ½Å°æÁ¶Àý
      • ½Å°æÇǵå¹é
      • ½Å°æ¾à¸®ÇÐ
      • ±âŸ
    • ½ÃÀå ¿¹Ãø
  • ½Å°æ¼ö¼ú
    • ½ÃÀå µ¿Çâ
    • ÁÖ¿ä ºÎ¹®
      • ±â´ÉÀû ½Å°æ¼ö¼ú
      • ±âŸ
    • ½ÃÀå ¿¹Ãø

Á¦9Àå ½ÃÀå ³»¿ª : ¿ëµµº°

  • ¿¬¼ö
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • Áø´Ü
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¼ö¼ú °èȹ°ú ÀçȰ
    • ½ÃÀå µ¿Çâ
    • ÁÖ¿ä ºÎ¹®
      • ¼ö¼úÀü
      • ¼ö¼úÁß
      • ¼ö¼úÈÄ
    • ½ÃÀå ¿¹Ãø
  • °á°ú¿Í ¸®½ºÅ© ºÐ¼®
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ÅëÇÕ°ú Á¢¼Ó
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±âŸ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦10Àå ½ÃÀå ³»¿ª : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±âŸ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦11Àå ½ÃÀå ³»¿ª : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦12Àå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ

  • °³¿ä
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ

Á¦13Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦14Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • °æÀï Á¤µµ
  • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦15Àå °¡°Ý ºÐ¼®

Á¦16Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • Activ Surgical
    • Caresyntax Corporation
    • DeepOR SAS
    • LeanTaaS
    • Medtronic Plc
    • Proximie Limited
    • Scalpel Limited
    • Surgalign Spine Technologies Inc.
ksm 25.02.12

The global artificial intelligence (AI) in neurology operating room market size reached USD 63.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,297 Million by 2033, exhibiting a growth rate (CAGR) of 39.8% during 2025-2033. The burgeoning healthcare industry, increasing utilization of AI in neurology operating rooms to predict cardiac and wound complications, and the growing demand for AI-based robotic surgeries represent some of the key factors driving the market.

Artificial intelligence (AI) is the simulation of human intelligence processes through computer programs and machines. It comprises expert systems, natural language processing, speech recognition, and machine vision. It relies on a foundation of enhanced hardware and software for writing and training machine learning (ML) algorithms. It is employed to reduce errors, perform risky tasks and automate various tasks without any breaks. It assists in collecting large amounts of labeled training data, analyzing the data for correlations and patterns, and using these patterns to make predictions about future states. It also aids in creating a specific task by acquiring data and converting the data into actionable information. At present, there is a rise in the demand for AI in the neurology operating room to enhance the performance of surgeons and reduce errors associated with neurosurgery.

Artificial Intelligence (AI) in Neurology Operating Room Market Trends:

The increasing demand for AI in neurology operating rooms to predict prognosis, identify potential post-operative complications, and track data for better aftercare and recovery represents one of the key factors supporting the market growth. Besides this, there is an increase in the utilization of AI in neurology operating rooms to identify risk factors and predict cardiac and wound complications and mortality among patients going through anterior cervical discectomy and fusion (ACDF) across the globe. This, along with the thriving healthcare industry, is propelling the growth of the market. In addition, the growing demand for AI in research centers of neurosurgery to collect, analyze, process, and disseminate data is offering a positive market outlook. Moreover, there is a rise in the employment of AI to diagnose epilepsy and tumor type, glioma, acute ischaemic events, and cerebral aneurysms around the world. This, coupled with the growing awareness among the masses about the benefits of AI-enabled surgeries over conventional surgeries, is positively influencing the market. Apart from this, the escalating demand for AI-based robotic surgeries that are minimally invasive (MI) and result in quick recovery and less blood loss is offering lucrative growth opportunities to industry investors. Additionally, the increasing application of AI to enhance remote surgical capabilities is bolstering the growth of the market.

Key Market Segmentation:

Offering Insights:

  • Hardware
  • Software-as-a-Service (SaaS)

Technology Insights:

  • Machine Learning (ML) and Deep Learning
  • Natural Language Processing (NLP)
  • Others

Indication Insights:

  • Neurotechnology
  • Neuromonitoring
  • Neuromodulation
  • Neurofeedback
  • Neuro-Pharmacology
  • Other Neurotechnology Indications
  • Neurosurgery
  • Functional Neurosurgery
  • Other Neurosurgery

Application Insights:

  • Training
  • Diagnosis
  • Surgical Planning and Rehabilitation
  • Pre-Operative
  • Intra-Operative
  • Post-Operative
  • Outcomes and Risk Analysis
  • Integration and Connectivity
  • Others

End User Insights:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, Europe was the largest market for artificial intelligence (AI) in neurology operating room. Some of the factors driving the Europe artificial intelligence (AI) in neurology operating room market included the implementation of AI in offering tailored precision medicine, adoption of information communication technology in the healthcare sector, the growing utilization of AI-enabled algorithms in detecting malignant tumors, etc.
  • Competitive Landscape
  • The report has also provided a comprehensive analysis of the competitive landscape in the global artificial intelligence (AI) in neurology operating room market. Detailed profiles of all major companies have also been provided. Some of the companies include Activ Surgical, Caresyntax Corporation, DeepOR SAS, LeanTaaS, Medtronic Plc, Proximie Limited, Scalpel Limited, Surgalign Spine Technologies Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global artificial intelligence (AI) in neurology operating room market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global artificial intelligence (AI) in neurology operating room market?
  • What are the key regional markets?
  • Which countries represent the most attractive artificial intelligence (AI) in neurology operating room markets?
  • What is the breakup of the market based on the offering?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What is the competitive structure of the global artificial intelligence (AI) in neurology operating room market?
  • Who are the key players/companies in the global artificial intelligence (AI) in neurology operating room market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Artificial Intelligence (AI) in Neurology Operating Room Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Offering

  • 6.1 Hardware
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Software-as-a-Service (SaaS)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Machine Learning (ML) and Deep Learning
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Natural Language Processing (NLP)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Indication

  • 8.1 Neurotechnology
    • 8.1.1 Market Trends
    • 8.1.2 Key Segments
      • 8.1.2.1 Neuromonitoring
      • 8.1.2.2 Neuromodulation
      • 8.1.2.3 Neurofeedback
      • 8.1.2.4 Neuro-Pharmacology
      • 8.1.2.5 Other Neurotechnology Indications
    • 8.1.3 Market Forecast
  • 8.2 Neurosurgery
    • 8.2.1 Market Trends
    • 8.2.2 Key Segments
      • 8.2.2.1 Functional Neurosurgery
      • 8.2.2.2 Other Neurosurgery
    • 8.2.3 Market Forecast

9 Market Breakup by Application

  • 9.1 Training
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diagnosis
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Surgical Planning and Rehabilitation
    • 9.3.1 Market Trends
    • 9.3.2 Key Segments
      • 9.3.2.1 Pre-Operative
      • 9.3.2.2 Intra-Operative
      • 9.3.2.3 Post-Operative
    • 9.3.3 Market Forecast
  • 9.4 Outcomes and Risk Analysis
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Integration and Connectivity
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 Others
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Ambulatory Surgical Centers
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 Drivers, Restraints, and Opportunities

  • 12.1 Overview
  • 12.2 Drivers
  • 12.3 Restraints
  • 12.4 Opportunities

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Activ Surgical
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 Caresyntax Corporation
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 DeepOR SAS
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 LeanTaaS
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Medtronic Plc
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 Proximie Limited
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Scalpel Limited
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Surgalign Spine Technologies Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦